2019 ACOI Exploring New Science in Cardiovascular Medicine

  • Register
    • Non-member - $481
    • Member - $373
    • Resident/Fellow - $120
    • Student - $120

This activity is designed for general cardiologists, interventional cardiologists, and electrophysiologists in clinical practice. At the completion of this program, learners will be able to:
- Define the clinical value of biomarkers in the DX and TX of heart failure;
- Discuss the optimal uses of LVAD technology for HF;
- Identify how advanced imaging techniques can improve early intervention in the ED and outcomes;
- Establish a patient-centered approach left atrial appendage occlusion vs. anticoagulant therapies;
- Discuss and evaluate the rationale behind the latest guidelines for hypertension in patients with T2DM;
- Apply case-derived insights to the use of anticoagulants.

This course was recorded May 9-12, 2019 in Baltimore, MD.

  • Contains 4 Component(s), Includes Credits Recorded On: 05/12/2019

    Recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 12, 2019 in Baltimore, MD.

    In this course the speaker will discuss the design, results and conclusions of The Compass Trial; review the previous and current literature regarding treatments for stable atherosclerotic vascular disease; discuss the use of anti-coagulation therapy in patients with stable atherosclerotic vascular disease. This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 12, 2019 in Baltimore, MD.

    Chad Link, DO, FACOI

    Assistant Clinical Professor

    Assistant Clinical Professor
    Michigan State University College of Osteopathic Medicine

    Cardiology Section Chairman
    Sparrow TCI

  • Contains 4 Component(s), Includes Credits Recorded On: 05/12/2019

    Recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 12, 2019 in Baltimore, MD.

    In this course the speaker will discuss the indications for anti-coagulation and anti-platelet therapy in patients with atrial fibrillation and coronary artery disease; review dual versus triple therapy in patients; undergoing percutaneous coronary intervention (PCI); review the previous and ongoing clinical trial results in patient on triple versus dual therapy. This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 12, 2019 in Baltimore, MD.

    Chad Link, DO, FACOI

    Assistant Clinical Professor

    Assistant Clinical Professor
    Michigan State University College of Osteopathic Medicine

    Cardiology Section Chairman
    Sparrow TCI

  • Contains 4 Component(s), Includes Credits Recorded On: 05/12/2019

    Recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 12, 2019 in Baltimore, MD.

    After completing this course the learner will understand the physiology of anticoagulation in pregnancy. This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 12, 2019 in Baltimore, MD.

    Saurabh Rajpal, MD

    Assistant Professor, Internal Medicine

    COACH Program 
    Adult Congenital Heart Disease & Pulmonary Hypertension Program
    The Heart Center Nationwide Children's Hospital 
    Ohio State University
    Columbus, OH

  • Contains 4 Component(s), Includes Credits Recorded On: 05/11/2019

    Recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    The speaker will discuss the increasing prevalence of adult congenital heart disease. This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    Saurabh Rajpal, MD

    Assistant Professor, Internal Medicine

    COACH Program 
    Adult Congenital Heart Disease & Pulmonary Hypertension Program
    The Heart Center Nationwide Children's Hospital 
    Ohio State University
    Columbus, OH

  • Contains 4 Component(s), Includes Credits Recorded On: 05/11/2019

    Recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    After completion of this activity the learner will understand differences between Transthyretin (ATTR) and Light Chain (AL). This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    Vikranth Gongidi, DO, FACOI

    Cardiologist

    Cardiologist

    Cleveland Clinic Indian River Medical Center

    Vero Beach, FL

  • Contains 4 Component(s), Includes Credits Recorded On: 05/11/2019

    Recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    The speaker will define hypertrophic cardiomyopathy and discuss the epidemiology/etiology, diagnosis, clinical evaluation, treatment of symptoms, treatment follow up, and special problems that can occur. This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    Robert J. Chilton, DO, MACOI

    Professor of Medicine

    Professor of Medicine, Associate Program Director for Interventional Cardiology at UTHSCSA

  • Contains 4 Component(s), Includes Credits Recorded On: 05/11/2019

    Recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    Upon completion of this course the learner will understand the definition of chemotherapy induced cardiomyopathy (CIMP). This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    Vikranth Gongidi, DO, FACOI

    Cardiologist

    Cardiologist

    Cleveland Clinic Indian River Medical Center

    Vero Beach, FL

  • Contains 4 Component(s), Includes Credits Recorded On: 05/11/2019

    Recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    After completing this lesson the learner will understand the basic principles of beta blocker use, translational considerations, clinical trials, and guidelines. This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    Robert J. Chilton, DO, MACOI

    Professor of Medicine

    Professor of Medicine, Associate Program Director for Interventional Cardiology at UTHSCSA

  • Contains 4 Component(s), Includes Credits Recorded On: 05/11/2019

    Recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    The speaker will discuss the physiology of blood pressure, types of shock, drugs for shock patients, and destination therapy. This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    Robert J. Chilton, DO, MACOI

    Professor of Medicine

    Professor of Medicine, Associate Program Director for Interventional Cardiology at UTHSCSA

  • Contains 4 Component(s), Includes Credits Recorded On: 05/11/2019

    Recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    The speaker will define advanced (Stage D) heart failure. This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 11, 2019 in Baltimore, MD.

    Christopher J. Sciamanna, DO, FACOI

    Clinical Assistant Professor of Medicine

    Advanced Heart Failure and Transplant Cardiology Clinical Assistant Professor of Medicine, University of Illinois at Chicago Advocate Christ Medical Center Oak Lawn, Illinois